If you look at their announcement back in April when they first...

If you look at their announcement back in April when they first notified the market of the FDA submission, they also flagged a few other things. They said:

"The Company intends to now proceed with work required for Australian TGA and European CE Mark
regulatory clearances.
Further work is in progress to apply AI to other organs and disease conditions, with the Company focusing
on developing and deploying efficient solutions for clinicians and radiologists globally to aid in the diagnosis,
monitoring, and management of patients"

Looks like an exciting announcement to come, imo.